(SOURCE: AUGUSTA UNIVERSITY) – Constant infusion of a drug now used intermittently to “rescue” patients with Parkinson’s from bouts of immobility may also help avoid these debilitating symptoms and smooth out their movement throughout the day, physician-scientists say. “As presently used, this therapy helps bridge a gap,” said Dr. Kapil D. Sethi, neurologist at the Medical […]
(SOURCE: UNIVERSITY OF NOTTINGHAM) – A fault with the natural waste disposal system that helps to keep our brain cell ‘batteries’ healthy may contribute to neurodegenerative disease, a new study has found. The research, led by academics at The University of Nottingham and published in the journal Cell Death and Disease, centres on problems with mitochondria — […]
(SOURCE: GEORGETOWN UNIVERSITY MEDICAL CENTER) – A synthesized steroid mirroring one naturally made by the dogfish shark prevents the buildup of a lethal protein implicated in some neurodegenerative diseases, reports an international research team studying an animal model of Parkinson’s disease. The clustering of this protein, alpha-synuclein (α-synuclein), is the hallmark of Parkinson’s and dementia with Lewy […]
(SOURCE: UNIVERSITY OF CAMBRIDGE) – Squalamine, a natural product studied for its anticancer and anti-infective properties, could also lead to future treatments for Parkinson’s Disease. A naturally-occurring compound has been found to block a molecular process thought to underlie Parkinson’s Disease, and to suppress its toxic products, scientists have reported. The findings, although only preliminary, suggest […]
(SOURCE: GLADSTONE INSTITUTES) – A new way to regulate protein levels and functions could be the answer to treating devastating neurological conditions. New details learned about a key cellular protein could lead to treatments for neurodegenerative diseases, such as Parkinson’s, Huntington’s, Alzheimer’s, and amyotrophic lateral sclerosis (ALS). At their root, these disorders are triggered by misbehaving proteins […]
(SOURCE: UNIVERSITY OF HELSINKI) – A research group led by University of Helsinki Docent Timo Myöhänen has succeeded in correcting the motor symptoms associated with Parkinson’s disease in mice. These results are promising in terms of treatment, since Parkinson’s disease is practically always diagnosed only after motor symptoms appear. Up to two per cent of people over […]
(SOURCE: Beth Israel Deaconess Medical Center – BIDMC) BOSTON – In a new study published online in the journal Neurology, a research team led by neurologists at Beth Israel Deaconess Medical Center (BIDMC) and neuropsychologists at Boston University has shown that when patients with Parkinson’s disease experience a drop in blood pressure upon standing up […]
(IOWA STATE UNIVERSITY) AMES, Iowa – A defect in a gene that produces dopamine in the brain appears to accelerate the onset of Parkinson’s disease, according to new research from Iowa State University. The effect is particularly dramatic for people under age 50. Auriel Willette, an assistant professor of food science and human nutrition; and […]
(MAYO CLINIC) According to a recent press release, a collaboration of 32 researchers in seven countries, led by scientists at Mayo Clinic’s campus in Florida, has found a genetic mutation they say confers a risk for development of Parkinson’s disease earlier than usual.
(AMERICAN FRIENDS OF TEL AVIV UNIVERSITY) According to a recent press release, a combination of virtual reality and treadmill training may prove effective in preventing dangerous falls associated with aging, Parkinson’s disease, mild cognitive impairment or dementia, according to a new Tel Aviv University-Tel Aviv Sourasky Medical Center (TASMC) study published in The Lancet.
(LUND UNIVERSITY) According to a recent Lund University press release, the first transplantation of stem cells in patients with Parkinson’s disease is almost within reach. However, it remains a challenge for researchers to control stem cells accurately in the lab in order to achieve successful and functional stem cell therapies for patients.
(Science Daily) According to an article recently published in Science Daily, a team, “reporting in the journal ACS Chemical Neuroscience, has identified how amyloid beta, the protein fragment strongly associated with Alzheimer’s disease, can induce cellular changes that might lead to Parkinson’s”.
(KABC) According to an article recently published in ABC7.com, a new type of FDA approved deep brain stimulator technology called Infinity may change the way people live with the disease.
(St. Louis Post Dispatch) According to a small study and recent article published in the St. Louis Post Dispatch, an inhaled version of the Parkinson’s drug levodopa is able to help when patients experience symptoms between doses of the pill form of the medication, according to a study published in the October 12 issue of Science […]
(National Parkinson Foundation) According to a recent article published in Parkinson.org, a team of researchers at Johns Hopkins University, have uncovered a potential new approach to treat Parkinson’s disease (PD) by focusing on a protein called lymphocyte-activation gene 3, known as LAG3.
(KHOU.com) According to a recent article published on KHOU.com (Houston), a new recently FDA approved drug called NUPLAZID can help combat the hallucinations caused by Parkinson’s disease psychosis. This drug offers new hope for anyone suffering from the condition.
(Medical Express) According to a recent article published in Medical Express, researchers at the University of Iowa have discovered that the gut may be key to preventing Parkinson’s disease.
9/23/16 (BBC) Research scientists at University College London (UCL) believe they may have discovered a method of detecting changes in the eye which could identify Parkinson’s disease before its symptoms develop. Researchers were able to detect changes in the back of rats’ eyes before symptoms of Parkinson’s disease became apparent. Currently, there is no brain […]
9/22/16 (ABC) As part of a clinical trial for Parkinson’s disease, Australian researchers have successfully injected stem cells into the brain of a 64-year-old Victorian man. According to the researchers at the Royal Melbourne Hospital, this novel treatment is the first of its kind in the world.